Correlation Between Zentalis Pharmaceuticals and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Transcode Therapeutics, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Transcode Therapeutics.
Diversification Opportunities for Zentalis Pharmaceuticals and Transcode Therapeutics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Zentalis and Transcode is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Transcode Therapeutics
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to generate 0.45 times more return on investment than Transcode Therapeutics. However, Zentalis Pharmaceuticals Llc is 2.22 times less risky than Transcode Therapeutics. It trades about -0.09 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 334.00 in Zentalis Pharmaceuticals Llc on December 5, 2024 and sell it today you would lose (147.00) from holding Zentalis Pharmaceuticals Llc or give up 44.01% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Transcode Therapeutics
Performance |
Timeline |
Zentalis Pharmaceuticals |
Transcode Therapeutics |
Zentalis Pharmaceuticals and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zentalis Pharmaceuticals and Transcode Therapeutics
The main advantage of trading using opposite Zentalis Pharmaceuticals and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |